MyFinsight
Home
Blog
About
Proceeds from maturities
of short-term...
$40,871K
(-49.25%↓ Y/Y)
Net cash provided by
investing activities
$15,686K
(-90.20%↓ Y/Y)
Canceled cashflow
$25,185K
Net (decrease)
increase in cash, cash...
-$5,145K
(-103.67%↓ Y/Y)
Canceled cashflow
$15,686K
Change in fair value of
warrant liabilities
$7,191K
(487.24%↑ Y/Y)
Stock-based compensation
expense
$3,369K
(-39.09%↓ Y/Y)
Accounts payable and
accrued expenses
$978K
(-24.83%↓ Y/Y)
Depreciation and
amortization
$665K
(-38.31%↓ Y/Y)
Deferred revenue
$252K
Non-cash interest
$235K
(-60.70%↓ Y/Y)
Amortization of right-of-use
lease assets
$168K
(-66.73%↓ Y/Y)
Inventory
-$133K
(-104.95%↓ Y/Y)
Accretion and interest on
short-term investments
-$77K
(73.45%↑ Y/Y)
Other receivables
-$14K
(36.36%↑ Y/Y)
Prepaid expenses and
other current assets
-$9K
(-100.95%↓ Y/Y)
Purchases of short-term
investments
$24,706K
(-63.93%↓ Y/Y)
Capital expenditures
$479K
(-88.87%↓ Y/Y)
Net cash used in
operating activities
-$17,496K
(52.95%↑ Y/Y)
Canceled cashflow
$13,091K
Net cash (used in)
provided by financing...
-$3,335K
(-119.32%↓ Y/Y)
Net (loss) income
-$20,191K
(-120.86%↓ Y/Y)
something is missing
-$7,000K
Accounts receivable
$3,194K
Lease liabilities
-$202K
(69.72%↑ Y/Y)
Payments of long-term
debt
$3,334K
Payments related to net
settlement of restricted...
$1K
(102.70%↑ Y/Y)
Back
Back
Cash Flow
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)
source: myfinsight.com